Items where Author is "Gill, Jennifer"

Number of items: 17.
Article
  • Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey. Gill, Jennifer and Baiceanu, Andrei and Clark, Paul J and Langford, Andrew and Latiff, Julianah and Yang, Pei-Ming and Yoshida, Eric M and Kanavos, Panos picture_as_pdf
  • International impact of external reference pricing:should national policy makers care? Fontrier, Anna-Maria and Gill, Jennifer and Kanavos, Panos picture_as_pdf
  • Variations in external reference pricing implementation:does it matter for public policy? Gill, Jennifer and Fontrier, Anna-Maria and Kyriopoulos, Dionysis and Kanavos, Panos description
  • Report
  • Access to medicines in Europe delays and challenges for patient access:delays and challenges for patient access. Kamphuis, Bregtje and Fontrier, Anna-Maria and Gill, Jennifer and Efthymiadou, Olina and Salyga, Hana and Kanavos, Panos
  • Access to personalised oncology in Europe. Gill, Jennifer and Fontrier, Anna-Maria and Miracolo, Aurelio and Kanavos, Panos
  • How can we improve secondary prevention of cardiovascular disease? Gill, Jennifer and Miracolo, Aurelio and Politopoulou, Konstantina and Jayawardana, Sahan and Carter, Alex and Apostolou, Efstratios A. and Kanavos, Panos picture_as_pdf
  • The Impact of External Reference Pricing within and across Countries. Kanavos, Panos and Fontrier, Anna-Maria and Gill, Jennifer and Efthymiadou, Olina and Boekstein, Nicola
  • The Implementation of External Reference Pricing within and across Country Borders. Kanavos, Panos and Fontrier, Anna-Maria and Gill, Jennifer and Kyriopoulos, Dionysis and Boekstein, Nicola
  • Improving Access to Contraception. Gill, Jennifer and Taylor, David
  • Latin America healthcare system overview:a comparative analysis of fiscal space in healthcare. Kanavos, Panos and Parkin, Georgia Colville and Kamphuis, Bregtje and Gill, Jennifer
  • RWE in Europe Paper II: The use of Real World Evidence in the disease context. Gill, Jennifer and Kanavos, Panos and Albanell, Joan and Dank, Magdolna and Duncombe, Robert and Fink-Wagner, Antje and Hutton, John and Jahnz-Różyk, Karina and Kossler, Ingrid and Podrazilova, Katerina and Schramm, Wolfgang and Spandonaro, Federico and Thomas, Michael and Wartenberg, Markus
  • RWE in Europe Paper III: A Roadmap for RWE. Gill, Jennifer and Albanell, Joan and Avouac, Bernard and Berger, Karin and Boerlum Kristensen, Finn and Bucher, Heiner C. and Duncombe, Robert and Fink-Wagner, Antje-Henriette and Hutton, John and Jahnz-Różyk, Karina and Kossler, Ingrid and Podrazilova, Katerina and Spandonaro, Federico and Thomas, Michael and Vaz-Carneiro, Antonio and Wartenberg, Markus and Kanavos, Panos
  • RWE in Europe Paper IV: Engaging pharma in the RWE Roadmap. Gill, Jennifer and Kanavos, Panos and d'Angela, Daniela and Berger, Karin and Dank, Magdolna and Duncombe, Robert and Fink-Wagner, Antje and Hutton, John and Kossler, Ingrid and Podrazilova, Katerina and Thomas, Michael
  • Sustainable healthcare financing for SDG3 in ASEAN-6. Gill, Jennifer and Chávez, Danitza and Main, Caitlin and Miracolo, Aurelio and Fontrier, Anna-Maria and Kanavos, Panos picture_as_pdf
  • Towards better outcomes in autism by addressing policy change. Efthymiadou, Olina and Kamphuis, Bregtje and Gill, Jennifer and Haig, Madeleine and Kanavos, Panos picture_as_pdf
  • The role of virtual health care and the pharmaceutical sector in improving population health. Kamphuis, Bregtje and Gill, Jennifer and Vogelzang, Michelle and Haig, Madeleine and Kanavos, Panos
  • The use of Real World Evidence in the European context: An analysis of key expert opinion. Gill, Jennifer and Kanavos, Panos and Avouac, Bernard and Duncombe, Robert and Hutton, John and Jahnz-Różyk, Karina and Schramm, Wolfgang and Spandonaro, Federico and Thomas, Michael